Replimune Group, Inc. (REPL)

7.26 +0.25 (+3.57%) USD  |  NASDAQ  |  Jan 21, 16:00
7.28 +0.02 (+0.28%) After-Hours: 05:03
More

Replimune Group EBIT (Quarterly)

EBIT (Quarterly) Chart

View EBIT (Quarterly) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBIT (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBIT Definition

View EBIT Definition
Start Trial

EBIT is an acronym for earnings before interest and taxes.

Read full definition.

EBIT (Quarterly) Range, Past 5 Years

View EBIT (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBIT (Quarterly) Benchmarks

View EBIT (Quarterly) Benchmarks
Start Trial
Rapt Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Anavex Life Sciences Corp. Upgrade